Core Insights - Worthington Steel, Inc. reported quarterly earnings of $0.77 per share, exceeding the Zacks Consensus Estimate of $0.72 per share, and showing an increase from $0.56 per share a year ago, resulting in an earnings surprise of +6.94% [1] - The company achieved revenues of $872.9 million for the quarter ended August 2025, surpassing the Zacks Consensus Estimate by 18.60% and up from $834 million year-over-year [2] - Worthington Steel's stock has increased by approximately 3.9% since the beginning of the year, while the S&P 500 has gained 13.2% [3] Earnings Outlook - The future performance of Worthington Steel's stock will largely depend on management's commentary during the earnings call and the company's earnings outlook [4] - The current consensus EPS estimate for the upcoming quarter is $0.49 on revenues of $727 million, and for the current fiscal year, it is $2.77 on revenues of $3.1 billion [7] Industry Context - The Steel - Specialty industry, to which Worthington Steel belongs, is currently ranked in the top 20% of over 250 Zacks industries, indicating a favorable outlook compared to the bottom 50% [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5]

Company Overview - Arq, Inc. (ARQ) shares increased by 5.1% to $7.36 in the last trading session, contrasting with a 1.7% loss over the past four weeks [1] - The price increase is attributed to improved contract terms, including growth in average selling prices and a surge in volumes [1] Earnings Expectations - Arq, Inc. is expected to report quarterly earnings of $0.02 per share, reflecting a year-over-year decline of 50% [2] - Revenue is anticipated to be $36.56 million, which is a 5.2% increase from the same quarter last year [2] Stock Performance Insights - The consensus EPS estimate for Arq, Inc. has remained unchanged over the last 30 days, indicating that stock price movements may not sustain without earnings estimate revisions [3] - The stock currently holds a Zacks Rank of 3 (Hold), suggesting a neutral outlook [3] Industry Comparison - Arq, Inc. operates within the Zacks Waste Removal Services industry, where Zurn Water (ZWS) is another player [3] - Zurn Water's consensus EPS estimate is $0.4, representing a year-over-year increase of 17.7%, and it holds a Zacks Rank of 1 (Strong Buy) [4]

Core Viewpoint - Brighthouse Financial (BHF) shares experienced a significant rally of 27.2%, closing at $57.59, largely driven by increased trading volume and news of a potential acquisition by Aquarian Holdings and other co-investors [1][2]. Company Overview - Brighthouse Financial is positioned to capitalize on growth opportunities through its extensive suite of life and annuity products, aiming to establish itself as a premier player in the industry [3]. - The company is revamping its life insurance business to enhance annuity sales and is focusing on transitioning to less capital-intensive products and reinsurance programs, which is expected to improve capital efficiencies [3]. Financial Performance Expectations - The company is projected to report quarterly earnings of $5.06 per share, reflecting a year-over-year increase of 26.8%, with revenues anticipated to reach $2.25 billion, up 3.3% from the previous year [4]. - The consensus EPS estimate for Brighthouse Financial has been slightly revised upward over the past 30 days, indicating a positive trend that typically correlates with stock price appreciation [5]. Industry Context - Brighthouse Financial operates within the Zacks Insurance - Life Insurance industry, where another company, GoHealth (GOCO), has seen a decline of 9.8% over the past month, closing at $4.71 [5]. - GoHealth's EPS estimate remains unchanged at -$2.06, which represents a year-over-year change of 44.8% [6].

Company Overview - Luxfer Holdings PLC (LXFR) shares increased by 5.4% to $14.77 in the last trading session, with a notable trading volume, and have gained 12.5% over the past four weeks [1] Market Performance - The recent rally in Luxfer's stock is attributed to positive sentiment regarding its strong performance in commercial and defense markets, driven by solid demand for products like magnesium powders and aerospace cylinders [2] - Additionally, increased sales of Meals Ready to Eat (MREs) and Group Rations (UGR-E) are contributing positively to the company's performance [2] Financial Expectations - Luxfer is projected to report quarterly earnings of $0.25 per share, reflecting a year-over-year decline of 10.7%, with expected revenues of $97 million, down 2.4% from the same quarter last year [3] Earnings Estimate Trends - The consensus EPS estimate for Luxfer has remained unchanged over the past 30 days, indicating that stock price movements may not sustain without trends in earnings estimate revisions [4][5] - The stock currently holds a Zacks Rank of 2 (Buy), suggesting a favorable outlook [5] Industry Comparison - Luxfer is part of the Zacks Manufacturing - General Industrial industry, where another company, Helios Technologies (HLIO), also showed positive performance, finishing 3.7% higher at $55.61 [5] - Helios Technologies has a consensus EPS estimate of $0.64 for its upcoming report, representing an 8.5% increase from the previous year, and holds a Zacks Rank of 1 (Strong Buy) [6]

Group 1 - Green Plains Renewable Energy (GPRE) shares increased by 7% to $10.28, with a notable trading volume, and have gained 26.1% over the past four weeks [1][2] - The recent rally is attributed to an agreement with Freepoint Commodities to monetize tax credits under 45Z, allowing the sale of Clean Fuel Production Credits from three Nebraska facilities [2] - The company is expected to report a quarterly loss of $0.13 per share, a year-over-year decline of 137.1%, with revenues projected at $548.25 million, down 16.8% from the previous year [3] Group 2 - The consensus EPS estimate for Green Plains has been revised 11.6% higher in the last 30 days, indicating a positive trend that may lead to price appreciation [4] - Green Plains holds a Zacks Rank of 3 (Hold), indicating a neutral outlook [5] - In the same industry, PPG Industries has a consensus EPS estimate of $2.12, unchanged over the past month, with a year-over-year change of -0.5% and also holds a Zacks Rank of 3 (Hold) [6]

Financial Performance - Scholastic reported a quarterly loss of $2.52 per share, which was worse than the Zacks Consensus Estimate of a loss of $2.44, and compared to a loss of $2.13 per share a year ago, indicating a decline in performance [1] - The company posted revenues of $225.6 million for the quarter ended August 2025, missing the Zacks Consensus Estimate by 5.57% and down from $237.2 million year-over-year [2] - Over the last four quarters, Scholastic has surpassed consensus EPS estimates two times and topped consensus revenue estimates just once [2] Stock Performance and Outlook - Scholastic shares have increased approximately 27.6% since the beginning of the year, outperforming the S&P 500's gain of 12.2% [3] - The current consensus EPS estimate for the upcoming quarter is $2.05 on revenues of $552.37 million, and for the current fiscal year, it is $1.23 on revenues of $1.66 billion [7] Industry Context - The Publishing - Books industry, to which Scholastic belongs, is currently ranked in the bottom 1% of over 250 Zacks industries, indicating a challenging environment [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which could impact Scholastic's stock performance [5]

Core Viewpoint - General Mills reported quarterly earnings of $0.86 per share, exceeding the Zacks Consensus Estimate of $0.81 per share, but down from $1.07 per share a year ago [1][2] Financial Performance - The earnings surprise for the quarter was +6.17%, with the company having surpassed consensus EPS estimates in all four of the last quarters [2] - Revenues for the quarter ended August 2025 were $4.52 billion, surpassing the Zacks Consensus Estimate by 0.42%, but down from $4.85 billion year-over-year [3] Stock Performance - General Mills shares have declined approximately 22.3% since the beginning of the year, contrasting with the S&P 500's gain of 12.3% [4] - The stock currently holds a Zacks Rank 4 (Sell), indicating expectations of underperformance in the near future [7] Future Outlook - The current consensus EPS estimate for the upcoming quarter is $1.09 on revenues of $4.81 billion, and for the current fiscal year, it is $3.65 on revenues of $18.65 billion [8] - The outlook for the industry, particularly the Food - Miscellaneous sector, is unfavorable, ranking in the bottom 30% of over 250 Zacks industries [9]

Group 1 - Evolution Petroleum reported quarterly earnings of $0.03 per share, exceeding the Zacks Consensus Estimate of $0.02 per share, with an earnings surprise of +50.00% [1] - The company posted revenues of $21.11 million for the quarter ended June 2025, missing the Zacks Consensus Estimate by 0.2%, and compared to year-ago revenues of $21.23 million [2] - Over the last four quarters, Evolution Petroleum has surpassed consensus EPS estimates just once and topped consensus revenue estimates only once [2] Group 2 - The stock has added about 0.8% since the beginning of the year, underperforming the S&P 500's gain of 12.5% [3] - The current consensus EPS estimate for the coming quarter is $0.01 on $21.5 million in revenues, and $0.09 on $87.9 million in revenues for the current fiscal year [7] - The Zacks Industry Rank for Oil and Gas - Exploration and Production - United States is currently in the bottom 28% of over 250 Zacks industries, indicating potential challenges for the sector [8]

Company Overview - Monte Rosa Therapeutics (GLUE) shares increased by 44.1% to close at $6.93, with trading volume significantly higher than usual [1] - The stock has gained 5% over the past four weeks [1] Collaboration Deal - Monte Rosa entered a multi-billion-dollar collaboration with Novartis to develop therapies for immune-mediated diseases [2] - Novartis will receive an exclusive license to a discovery target developed using Monte Rosa's proprietary platform and options to license two programs from GLUE's preclinical immunology portfolio [2] Financial Terms of the Deal - Monte Rosa will receive an upfront payment of $120 million, along with option maintenance payments [3] - The total potential value of the deal is up to $5.7 billion, including royalties on future sales of the drug [3] Earnings Expectations - Monte Rosa is expected to report a quarterly loss of $0.28 per share, reflecting a year-over-year change of +3.5% [4] - Revenue is projected to be $14.07 million, up 52.6% from the same quarter last year [4] Stock Performance Insights - The consensus EPS estimate for Monte Rosa has remained unchanged over the last 30 days, indicating that stock price movements may not continue without earnings estimate revisions [5] - Monte Rosa currently holds a Zacks Rank of 3 (Hold) [5]

Core Viewpoint - Hain Celestial reported a quarterly loss of $0.02 per share, missing the Zacks Consensus Estimate of $0.04, and showing a significant decline from earnings of $0.13 per share a year ago, indicating a negative earnings surprise of -150.00% [1] Financial Performance - The company posted revenues of $363.35 million for the quarter ended June 2025, which was 3.21% below the Zacks Consensus Estimate and a decrease from $418.8 million in the same quarter last year [2] - Over the last four quarters, Hain Celestial has not surpassed consensus EPS estimates and has only topped revenue estimates once [2] Stock Performance - Hain Celestial shares have declined approximately 65% since the beginning of the year, contrasting with a 12% gain in the S&P 500 [3] - The current consensus EPS estimate for the upcoming quarter is -$0.02 on revenues of $373.22 million, while for the current fiscal year, the estimate is $0.23 on revenues of $1.53 billion [7] Industry Outlook - The Zacks Industry Rank for Food - Miscellaneous, which includes Hain Celestial, is currently in the bottom 35% of over 250 Zacks industries, suggesting potential challenges ahead [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which could impact Hain Celestial's stock performance [5]